AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 11 min read$KMTS

COHEN RAYMOND W sold $98K of KMTS

COHEN RAYMOND W sold 3,330 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $29.28 on 2026-09-30.

Original reporting
SEC EDGAR · COHEN RAYMOND W
Published Oct 1, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 10:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$KMTS
Bearish
medium confidence
Mentioned
$KMTS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KMTSBearishLow
01

Why it matters

The disclosed sale is the first public report of this insider activity.

02

Market read

Small insider sale with limited market impact; useful for compliance monitoring.

03

What to watch

Director's overall stake remains sizable; no 10b5-1 plan indicates discretionary sale.

Relevance 3/10Novelty 3/10Timing: today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$KMTSBearishMedium confidence
Context

Director Cohen Raymond W sold 3,330 shares for $97,504, reducing his holdings to 54,790 shares.

Expected impact

potential slight pressure as the market prices in the insider sale

Evidence & confidence

The transaction is a modest $97k sale by a director; such sales typically have limited impact but can nudge the stock lower.

Market effects

Sector

Minimal effect on the broader medical device sector.

Regional

No significant regional impact.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The sale may be routine portfolio rebalancing, not a negative signal.

Key entities

  • Company
    Kestral Medical Technologies, Ltd.

    Medical device manufacturer listed on Nasdaq under ticker KMTS.

  • Person
    Cohen Raymond W

    Director of KMTS who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

KMTS insider trading history →

Related articles

SEP 16
$KMTSHighAI 8/10

Kestra Medical Technologies Signals Profitable Growth Path

Kestra Medical Technologies (KMTS) reported Q1 revenue of $31M, up 60% YoY, with gross margin at 56.5%, up from 45.7% YoY. The company raised 2027 revenue guidance to $141M and expects profitability within a few years. Management highlighted strong growth drivers, including market expansion and automation.

tipranks.com3 min
SEP 15
$KMTSMed

Kestra (KMTS) Q1 2027 Earnings Call Transcript

Kestra Medical Technologies (KMTS) reported Q1 2027 revenue of $31.0M, up 60% YoY, and raised full-year guidance to $141M. Gross margin increased to 56.5%, driven by volume leverage and cost improvements. The company invested heavily in R&D and commercial expansion, resulting in a GAAP net loss of $44.1M. Management highlighted market share gains and expanded payer coverage for non-ischemic patients.

aol.com2 min
SEP 15
$KMTSMedAI 8/10

Kestra Medical Technologies Ltd (KMTS) (Q1 2027) Earnings Call Highlights: Revenue Jumps 60%

Kestra Medical Technologies (KMTS) reported Q1 2027 revenue growth of 60% but saw increased operating expenses and net loss. The company raised its full-year guidance to $141M, expecting 48% growth. Gross margins expanded for 11 consecutive quarters, with confidence in reaching mid-70% margins. R&D spend increased significantly due to a late-stage project but is expected to normalize. Management attributed growth to prescription volume, in-network mix, and field team expansion.

yahoo.com3 min
SEP 14
$KMTSHigh

Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results KIRKLAND, Wash., September 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported

SEC EDGAR 8-K2 min